In the Notice of Initiation, the Commission announced that the product under investigation is choline chloride, in all forms and purities, whether or not on a carrier, with a minimum choline chloride content of 30 % by weight, excluding calcium phosphoryl choline chloride tetrahydrate. Interested parties were informed that comments on the product scope should be provided to the Commission within 10 days of the date of publication of the Notice of Initiation. CFNA had not provided any comments until the submission referred to in the previous recital. Moreover, its claim of different market dynamics was not substantiated. The claim of CFNA is therefore rejected.
43 2. PRODUCT CONCERNED AND LIKE PRODUCT › 2.2. Claims regarding product scope › 2.2.2. Other product scope claims, Regulation (EU) 2025/2589
In forcesince 18 Dec 2025